Consistent with the findings of other investigators, our data convincingly demonstrate that FcγRIIb is required for the protective effects of IVIG in a model of ITP (Figure 5B) [24,25]. This evidence concerns the gene FCGR2B and autoimmune thrombocytopenic purpura.